ebomi
Colour theme
Sign in
Insider · CIK 0001598292

EcoR1 Capital Fund Qualified, L.P.

CIK 0001598292 Name as filed on the most recent filing

Filed as EcoR1 Capital Fund Qualified, L.P. (13)

50 transaction lines · from 13 filings · filed 2014-03-28 to 2023-09-22 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

18 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2023-09-21 Nuvation Bio Inc.
NUVB 		P, Open-market purchase 53,000 acquired 1.36 72,138.30 Form 4, filing 0000935836-23-000621
2023-09-20 Nuvation Bio Inc.
NUVB 		P, Open-market purchase 117,100 acquired 1.36 159,490.20 Form 4, filing 0000935836-23-000621
2023-09-19 Nuvation Bio Inc.
NUVB 		P, Open-market purchase 5,143,000 acquired 1.26 6,460,636.60 Form 4, filing 0000935836-23-000621
2023-02-21 Nuvation Bio Inc.
NUVB 		P, Open-market purchase 53,000 acquired 1.36 72,138.30 Form 4, filing 0000935836-23-000619
2023-02-20 Nuvation Bio Inc.
NUVB 		P, Open-market purchase 117,100 acquired 1.36 159,490.20 Form 4, filing 0000935836-23-000619
2023-02-19 Nuvation Bio Inc.
NUVB 		P, Open-market purchase 5,143,000 acquired 1.26 6,460,636.60 Form 4, filing 0000935836-23-000619
2021-11-24 Nuvation Bio Inc.
NUVB 		P, Open-market purchase 163,268 acquired 7.69 1,254,861.52 Form 4, filing 0001567619-21-021329
2021-11-24 Nuvation Bio Inc.
NUVB 		P, Open-market purchase 21,758 acquired 7.69 167,229.81 Form 4, filing 0001567619-21-021329
2021-07-31 Nuvation Bio Inc.
NUVB 		S, Open-market sale 56,598 disposed 8.64 489,006.72 Form 4, filing 0001567619-21-021329
2021-07-31 Nuvation Bio Inc.
NUVB 		P, Open-market purchase 56,598 acquired 8.64 489,006.72 Form 4, filing 0001567619-21-021329
2021-04-13 Nuvation Bio Inc.
NUVB 		P, Open-market purchase 27,534 acquired 10.27 282,801.71 Form 4, filing 0001567619-21-007976
2021-04-13 Nuvation Bio Inc.
NUVB 		P, Open-market purchase 3,966 acquired 10.27 40,734.79 Form 4, filing 0001567619-21-007976
2021-04-12 Nuvation Bio Inc.
NUVB 		P, Open-market purchase 116,255 acquired 9.49 1,103,004.19 Form 4, filing 0001567619-21-007976
2021-04-12 Nuvation Bio Inc.
NUVB 		P, Open-market purchase 16,745 acquired 9.49 158,873.21 Form 4, filing 0001567619-21-007976
2021-04-09 Panacea Acquisition Corp. II
PANA 		P, Open-market purchase 545,000 acquired 10.00 5,450,000.00 Form 4, filing 0001213900-21-021365
2021-04-09 Nuvation Bio Inc.
NUVB 		P, Open-market purchase 262,230 acquired 10.03 2,630,324.24 Form 4, filing 0001567619-21-007976
2021-04-09 Nuvation Bio Inc.
NUVB 		P, Open-market purchase 37,770 acquired 10.03 378,855.76 Form 4, filing 0001567619-21-007976
2021-03-31 Nuvation Bio Inc.
NUVB 		S, Open-market sale 151,544 acquired 10.45 1,583,634.80 Form 4, filing 0001567619-21-021329
2021-03-31 Nuvation Bio Inc.
NUVB 		P, Open-market purchase 151,544 acquired 10.45 1,583,634.80 Form 4, filing 0001567619-21-021329
2020-07-06 Panacea Acquisition Corp
PANA 		P, Open-market purchase 390,000 acquired 10.00 3,900,000.00 Form 4, filing 0001213900-20-016762
2018-12-21 Kura Oncology, Inc.
KURA 		P, Open-market purchase 83,540 acquired 13.16 1,099,386.40 Form 4, filing 0001567619-19-000984
2018-12-19 Kura Oncology, Inc.
KURA 		P, Open-market purchase 51,879 acquired 13.84 718,005.36 Form 4, filing 0001567619-19-000984
2018-12-18 Kura Oncology, Inc.
KURA 		P, Open-market purchase 78,469 acquired 13.82 1,084,441.58 Form 4, filing 0001567619-19-000984
2018-12-17 Kura Oncology, Inc.
KURA 		S, Open-market sale 26,520 disposed 13.20 350,064.00 Form 4, filing 0001567619-19-000984
2018-12-13 Kura Oncology, Inc.
KURA 		P, Open-market purchase 25,217 acquired 13.89 350,264.13 Form 4, filing 0001567619-18-007956
2018-12-11 Kura Oncology, Inc.
KURA 		P, Open-market purchase 15,321 acquired 13.91 213,098.26 Form 4, filing 0001567619-18-007956
2018-12-06 Kura Oncology, Inc.
KURA 		P, Open-market purchase 17,079 acquired 13.49 230,395.71 Form 4, filing 0001567619-18-007453
2018-12-04 Kura Oncology, Inc.
KURA 		P, Open-market purchase 54,645 acquired 13.08 714,756.60 Form 4, filing 0001567619-18-007453
2018-12-03 Kura Oncology, Inc.
KURA 		P, Open-market purchase 48,182 acquired 13.97 673,102.54 Form 4, filing 0001567619-18-007453
2018-05-16 aTYR Pharma Inc
LIFE 		S, Open-market sale 2,733,231 disposed 0.81 2,216,923.66 Form 4, filing 0001140361-18-024271
2018-05-15 aTYR Pharma Inc
LIFE 		S, Open-market sale 121,294 disposed 1.43 173,062.28 Form 4, filing 0001140361-18-024271
2018-05-14 aTYR Pharma Inc
LIFE 		S, Open-market sale 354,791 disposed 1.72 609,069.71 Form 4, filing 0001140361-18-024271
2017-11-13 aTYR Pharma Inc
ATYR 		S, Open-market sale 1,083 disposed 3.95 4,277.85 Form 4, filing 0001140361-17-046221
2017-11-10 aTYR Pharma Inc
ATYR 		S, Open-market sale 5,860 disposed 4.00 23,444.69 Form 4, filing 0001140361-17-046221
2017-11-09 aTYR Pharma Inc
ATYR 		S, Open-market sale 5,819 disposed 4.15 24,151.18 Form 4, filing 0001140361-17-046221
2017-11-08 aTYR Pharma Inc
ATYR 		S, Open-market sale 1,070 disposed 4.30 4,601.00 Form 4, filing 0001140361-17-046221
2017-11-01 aTYR Pharma Inc
ATYR 		P, Open-market purchase 24,728 acquired 4.80 118,694.40 Form 4, filing 0001140361-17-046221
2017-10-01 aTYR Pharma Inc
ATYR 		P, Open-market purchase 4,879 acquired 5.05 24,638.95 Form 4, filing 0001140361-17-046221
2014-05-27 Genvec Inc
GNVC 		P, Open-market purchase 4,662 acquired 2.39 11,149.64 Form 4, filing 0000921895-14-001307
2014-05-27 Genvec Inc
GNVC 		P, Open-market purchase 4,378 acquired 2.39 10,470.42 Form 4, filing 0000921895-14-001307
2014-05-23 Genvec Inc
GNVC 		P, Open-market purchase 2,372 acquired 2.19 5,205.59 Form 4, filing 0000921895-14-001307
2014-05-23 Genvec Inc
GNVC 		P, Open-market purchase 2,228 acquired 2.19 4,889.57 Form 4, filing 0000921895-14-001307
2014-05-22 Genvec Inc
GNVC 		P, Open-market purchase 5,415 acquired 2.13 11,535.03 Form 4, filing 0000921895-14-001307
2014-05-22 Genvec Inc
GNVC 		P, Open-market purchase 5,085 acquired 2.13 10,832.07 Form 4, filing 0000921895-14-001307
2014-03-28 Genvec Inc
GNVC 		P, Open-market purchase 28,509 acquired 2.73 77,909.40 Form 4, filing 0000921895-14-000680
2014-03-28 Genvec Inc
GNVC 		P, Open-market purchase 19,006 acquired 2.73 51,939.60 Form 4, filing 0000921895-14-000680
2014-03-27 Genvec Inc
GNVC 		P, Open-market purchase 30,729 acquired 2.49 76,585.89 Form 4, filing 0000921895-14-000680
2014-03-27 Genvec Inc
GNVC 		P, Open-market purchase 20,486 acquired 2.49 51,057.26 Form 4, filing 0000921895-14-000680
2014-03-26 Genvec Inc
GNVC 		P, Open-market purchase 14,126 acquired 2.31 32,694.63 Form 4, filing 0000921895-14-000680
2014-03-26 Genvec Inc
GNVC 		P, Open-market purchase 9,417 acquired 2.31 21,795.65 Form 4, filing 0000921895-14-000680

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 10
  • Open-market sale 8
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. EcoR1 Capital Fund Qualified, L.P., insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001598292

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.